Pamoja Therapeutics

Pamoja Therapeutics is a mission-driven biotechnology company focused on developing affordable and accessible pediatric formulations for neglected diseases, with a primary focus on pediatric HIV/AIDS. The company utilizes reformulation technologies to convert existing adult medications into child-friendly formats, such as dispersible tablets or fixed-dose combinations, which are easier to administer in low-resource settings. By bridging the 'pediatric gap' in global medicine, Pamoja aims to reduce mortality rates for children in low- and middle-income countries. The enterprise operates as a social venture, balancing financial sustainability with a commitment to high-impact global health outcomes. Their pipeline primarily focuses on optimizing treatment regimens for infants and young children who lack access to age-appropriate drug delivery systems.